游离小腿后外侧腓动脉穿支皮瓣修复口咽癌术后缺损的效果分析

崔文静, 卓凤, 王续纪, 等. 游离小腿后外侧腓动脉穿支皮瓣修复口咽癌术后缺损的效果分析[J]. 临床耳鼻咽喉头颈外科杂志, 2023, 37(1): 52-58. doi: 10.13201/j.issn.2096-7993.2023.01.010
引用本文: 崔文静, 卓凤, 王续纪, 等. 游离小腿后外侧腓动脉穿支皮瓣修复口咽癌术后缺损的效果分析[J]. 临床耳鼻咽喉头颈外科杂志, 2023, 37(1): 52-58. doi: 10.13201/j.issn.2096-7993.2023.01.010
CUI Wenjing, ZHUO Feng, WANG Xuji, et al. Analysis of the effect of free posterior lateral peroneal artery perforator flap of lower leg in repairing oropharyngeal cancer[J]. J Clin Otorhinolaryngol Head Neck Surg, 2023, 37(1): 52-58. doi: 10.13201/j.issn.2096-7993.2023.01.010
Citation: CUI Wenjing, ZHUO Feng, WANG Xuji, et al. Analysis of the effect of free posterior lateral peroneal artery perforator flap of lower leg in repairing oropharyngeal cancer[J]. J Clin Otorhinolaryngol Head Neck Surg, 2023, 37(1): 52-58. doi: 10.13201/j.issn.2096-7993.2023.01.010

游离小腿后外侧腓动脉穿支皮瓣修复口咽癌术后缺损的效果分析

  • 基金项目:
    安徽省高校合作攻关和公共卫生协同创新项目(No:GXXT-2020-021)
详细信息
    通讯作者: 李建成,E-mail:ljc7426@163.com
  • 中图分类号: R739.8

Analysis of the effect of free posterior lateral peroneal artery perforator flap of lower leg in repairing oropharyngeal cancer

More Information
  • 目的 分析游离小腿后外侧腓动脉穿支皮瓣修复口咽癌术后缺损的临床效果。方法 对2016年6月—2019年6月蚌埠医学院第一附属医院口腔颌面外科收治的36例口咽癌患者进行分析和随访,18例患者采用游离小腿后外侧腓动脉穿支皮瓣修复术后缺损(实验组),18例采用游离前臂皮瓣修复(对照组),比较两组患者移植皮瓣成活率、伤口Ⅰ期愈合率及平均住院时间;采用Kaplan-Meier法计算患者术后1、3年生存率,log-rank检验比较两组生存曲线间差异;通过洼田饮水试验、吹气法计算并统计分析两组患者术后3、6、12、18个月吞咽、腭咽闭合功能恢复情况。结果 实验组与对照组均有1例皮瓣坏死,成活率均为94.4%;两组患者术区伤口Ⅰ期愈合率均为94.4%;实验组和对照组供区伤口愈合率分别为100.0%和94.4%;实验组和对照组平均住院时间分别为16.9 d和17.2 d,差异无统计学意义(P>0.05)。所有患者1、3年总体生存率为91.2%、66.5%;实验组和对照组1、3年生存率分别为94.1%、69.3%和88.2%、63.7%,两组比较差异无统计学意义(P>0.05);P16+和P16-患者术后1、3年生存率分别为100.0%、80.0%和85.7%、64.3%,两组比较差异无统计学意义(P>0.05)。术后3、6个月两组患者吞咽及腭咽闭合功能恢复评价的差异无统计学意义(P>0.05),术后12、18个月差异有统计学意义(P<0.05)。结论 游离小腿后外侧腓动脉穿支皮瓣穿支血管解剖恒定,可根据组织缺损空间制备成单叶、多叶、嵌合等皮瓣,且供区隐蔽可直接拉拢缝合,同时该皮瓣可塑性较强,因此可作为修复口咽癌术后缺损的常用皮瓣。
  • 加载中
  • 图 1  实验组与对照组术后生存曲线比较

    图 2  P16+和P16-患者术后生存曲线比较

    图 3  54岁女性右舌根鳞状细胞癌患者资料

    表 1  两组患者一般资料比较 例(%)

    项目 对照组(n=18) 实验组(n=18) χ2 P 项目 对照组(n=18) 实验组(n=18) χ2 P
    性别 0.120 0.729 病理分级 1.453 0.693
      男 11(61.1) 12(66.7)   高分化 4(22.2) 6(33.3)
      女 7(38.9) 6(33.3)   中分化 10(55.6) 9(50.0)
    发病部位 0.521 0.914   低分化 3(16.7) 3(16.7)
      扁桃体 5(27.8) 4(22.2)   未分化 1(5.6) 0(0)
      舌根 7(38.9) 6(33.3) HPV分型 0.177 0.674
      软腭 5(27.8) 7(38.9)   HPV+ 4(22.2) 3(16.7)
      咽后壁 1(5.6) 1(5.6)   HPV- 14(77.8) 15(83.3)
    cTNM分期 0.582 0.748 清扫范围 0.170 0.919
      Ⅱ期 2(11.1) 2(11.1)   Ⅰ~Ⅲ区 5(27.8) 5(27.8)
      Ⅲ期 12(66.7) 10(55.6)   Ⅰ~Ⅳ区 8(44.4) 9(50.0)
      Ⅳ期 4(22.2) 6(33.3)   Ⅰ~Ⅴ区 5(27.8) 4(22.2)
    T分期 1.209 0.598 术后放疗剂量/Gy 0.253 0.881
      T1~T2 2(11.1) 3(16.7)   44~50 9(50.0) 10(55.6)
      T3 12(66.7) 9(50.0)   54~63 6(33.3) 6(33.3)
      T4a 4(22.2) 6(33.3)   60~66 3(16.7) 2(11.1)
    N分级 1.117 0.773
      N0 3(16.7) 2(11.1)
      N1 9(50.0) 7(38.9)
      N2 5(27.8) 7(38.9)
      N3 1(5.6) 2(11.1)
    下载: 导出CSV

    表 2  术后两组患者吞咽功能恢复评价比较

    随访时间/月 对照组 实验组 χ2 P
    正常 可疑 异常 正常 可疑 异常
    3 0 5 12 0 7 10 0.515 0.473
    6 1 11 5 2 11 3 0.804 0.669
    12 2 11 2 10 5 1 7.893 0.019
    18 8 6 0 14 0 1 8.612 0.013
    下载: 导出CSV

    表 3  术后两组患者腭咽闭合功能恢复评价比较

    随访时间/月 对照组 实验组 χ2 P
    正常 可疑 异常 正常 可疑 异常
    3 0 6 11 0 8 9 0.486 0.486
    6 1 8 8 3 8 5 1.664 0.435
    12 3 9 3 11 4 1 7.470 0.024
    18 8 6 0 14 1 0 5.179 0.023
    下载: 导出CSV
  • [1]

    Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022[J]. CA Cancer J Clin, 2022, 72(5): 409-436. doi: 10.3322/caac.21731

    [2]

    Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022[J]. CA Cancer J Clin, 2022, 72(1): 7-33. doi: 10.3322/caac.21708

    [3]

    Panarese I, Aquino G, Ronchi A, et al. Oral and Oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route[J]. Expert Rev Anticancer Ther, 2019, 19(2): 105-119. doi: 10.1080/14737140.2019.1561288

    [4]

    Szymonowicz KA, Chen J. Biological and clinical aspects of HPV-related cancers[J]. Cancer Biol Med, 2020, 17(4): 864-878. doi: 10.20892/j.issn.2095-3941.2020.0370

    [5]

    Gormley M, Dudding T, Sanderson E, et al. A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancer[J]. Nat Commun, 2020, 11(1): 6071. doi: 10.1038/s41467-020-19822-6

    [6]

    Du E, Mazul AL, Farquhar D, et al. Long-term Survival in Head and Neck Cancer: Impact of Site, Stage, Smoking, and Human Papillomavirus Status[J]. Laryngoscope, 2019, 129(11): 2506-2513. doi: 10.1002/lary.27807

    [7]

    Vawda N, Banerjee RN, Debenham BJ. Impact of Smoking on Outcomes of HPV-related Oropharyngeal Cancer Treated with Primary Radiation or Surgery[J]. Int J Radiat Oncol Biol Phys, 2019, 103(5): 1125-1131. doi: 10.1016/j.ijrobp.2018.11.046

    [8]

    Gillison ML, Akagi K, Xiao W, et al. Human papillomavirus and the landscape of secondary genetic alterations in oral cancers[J]. Genome Res, 2019, 29(1): 1-17. doi: 10.1101/gr.241141.118

    [9]

    Asthana S, Labani S, Kailash U, et al. Association of Smokeless Tobacco Use and Oral Cancer: A Systematic Global Review and Meta-Analysis[J]. Nicotine Tob Res, 2019, 21(9): 1162-1171. doi: 10.1093/ntr/nty074

    [10]

    You EL, Henry M, Zeitouni AG. Human papillomavirus-associated oropharyngeal cancer: review of current evidence and management[J]. Curr Oncol, 2019, 26(2): 119-123. doi: 10.3747/co.26.4819

    [11]

    Matos LL, Dedivitis RA, Kulcsar M, et al. External validation of the AJCC Cancer Staging Manual, 8th edition, in an independent cohort of oral cancer patients[J]. Oral Oncol, 2017, 71: 47-53. doi: 10.1016/j.oraloncology.2017.05.020

    [12]

    Colevas AD, Yom SS, Pfister DG, et al. NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018[J]. J Natl Compr Canc Netw, 2018, 16(5): 479-490. doi: 10.6004/jnccn.2018.0026

    [13]

    郭蕴, 崔文静, 宗开洋, 等. 红外热成像技术辅助腓动脉穿支皮瓣修复口腔颌面部缺损的应用研究[J]. 中国修复重建外科杂志, 2022, 36(8): 1015-1020. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXCW202208015.htm

    [14]

    李建成, 杨东昆, 宋培军, 等. 游离皮瓣移植在全舌切除后Ⅰ期修复重建中的应用[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(8): 736-742. https://lceh.cbpt.cnki.net/WKC/WebPublication/paperDigest.aspx?paperID=88dacbea-5bf2-4105-ace7-e24ac3acff6e

    [15]

    孙悦, 郭蕴, 李建成, 等. 游离小腿后外侧腓动脉穿支皮瓣在全舌、次全舌切除术后修复中的临床应用[J]. 中华整形外科杂志, 2021, 37(11): 1214-1221. doi: 10.3760/cma.j.cn114453-20201010-00526

    [16]

    赵佳雄, 南欣荣. 股前外侧皮瓣与前臂皮瓣修复口咽癌术后缺损的功能评价[J]. 临床耳鼻咽喉头颈外科杂志, 2021, 35(12): 1107-1110. https://lceh.cbpt.cnki.net/WKC/WebPublication/paperDigest.aspx?paperID=9096f022-0d55-4dd2-8fe8-e48cfab54866

    [17]

    李建成, 郭蕴, 崔文静, 等. 治疗方式对中晚期人乳头状瘤病毒阴性口咽癌患者的生存率和生存质量的影响[J]. 南方医科大学学报, 2022, 42(8): 1230-1236. https://www.cnki.com.cn/Article/CJFDTOTAL-DYJD202208016.htm

    [18]

    Zhang Y, Fakhry C, D'Souza G. Projected Association of Human Papillomavirus Vaccination With Oropharynx Cancer Incidence in the US, 2020-2045[J]. JAMA Oncol, 2021, 7(10): e212907. doi: 10.1001/jamaoncol.2021.2907

    [19]

    Taku N, Wang L, Garden AS, et al. Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy[J]. Curr Treat Options Oncol, 2021, 22(6): 54. doi: 10.1007/s11864-021-00847-y

    [20]

    张永侠, 刘明波, 黄辉, 等. 第七版与第八版美国癌症联合会TNM分期对口咽癌预后生存的分析比较[J]. 临床耳鼻咽喉头颈外科杂志, 2019, 33(7): 586-590. https://lceh.cbpt.cnki.net/WKC/WebPublication/paperDigest.aspx?paperID=e76cf8b1-3b1f-4cb2-a4d9-7f5fb4be7f7c

    [21]

    Gangwani K, Shetty L, Seshagiri R, et al. Comparison of TORS with Conventional Surgery for Oropharyngeal Carcinomas in T1-T4 Lesions[J]. Ann Maxillofac Surg, 2019, 9(2): 387-392. doi: 10.4103/ams.ams_33_18

    [22]

    Park DA, Lee MJ, Kim SH, et al. Comparative safety and effectiveness of transoral robotic surgery versus open surgery for oropharyngeal cancer: A systematic review and meta-analysis[J]. Eur J Surg Oncol, 2020, 46(4 Pt A): 644-649.

    [23]

    Bozec A, Majoufre C, De Boutray M, et al. Oral and oropharyngeal cancer surgery with free-flap reconstruction in the elderly: Factors associated with long-term quality of life, patient needs and concerns. A GETTEC cross-sectional study[J]. Surg Oncol, 2020, 35: 81-88.

    [24]

    Scott SI, Kathrine Ø Madsen A, Rubek N, et al. Long-term quality of life & functional outcomes after treatment of oropharyngeal cancer[J]. Cancer Med, 2021, 10(2): 483-495.

    [25]

    Xu MJ, Plonowska KA, Gurman ZR, et al. Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer[J]. Laryngoscope, 2020, 130(2): E48-E56.

    [26]

    Sims JR, Moore EJ. Primary surgical management with radial forearm free flap reconstruction in T4 oropharyngeal cancer: Complications and functional outcomes[J]. Am J Otolaryngol, 2018, 39(2): 116-121.

    [27]

    Bozec A, Demez P, Gal J, et al. Long-term quality of life and psycho-social outcomes after oropharyngeal cancer surgery and radial forearm free-flap reconstruction: A GETTEC prospective multicentric study[J]. Surg Oncol, 2018, 27(1): 23-30.

    [28]

    Li J, Song P, Yang D, et al. Complicated intraoral defects: reconstruction using a three-paddle perforator free flap. A case report[J]. Br J Oral Maxillofac Surg, 2020, 58(3): 355-357.

    [29]

    李建成, 宋培军, 杨东昆, 等. 游离腓动脉双叶穿支皮瓣在晚期口咽癌术后缺损解剖重建中的临床效果[J]. 南方医科大学学报, 2020, 40(6): 814-821. https://www.cnki.com.cn/Article/CJFDTOTAL-DYJD202006008.htm

    [30]

    郭蕴, 孙悦, 李建成, 等. 经口入路口腔-口咽癌切除临床分析[J]. 临床耳鼻咽喉头颈外科杂志, 2021, 35(8): 712-717. https://lceh.cbpt.cnki.net/WKC/WebPublication/paperDigest.aspx?paperID=915153f4-b424-4039-ae29-e864cefcba14

    [31]

    杨东昆, 李建成, 吴志刚, 等. 游离腓动脉嵌合穿支皮瓣修复腮腺癌晚期局部病变术后缺损[J]. 中国修复重建外科杂志, 2022, 36(1): 79-85. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXCW202201009.htm

  • 加载中

(3)

(3)

计量
  • 文章访问数:  1006
  • PDF下载数:  145
  • 施引文献:  0
出版历程
收稿日期:  2022-09-08
刊出日期:  2023-01-03

目录